Apremilast for the Treatment of Moderate to Severe Plaque Psoriasis: A Critique of the Evidence
Crossref DOI link: https://doi.org/10.1007/s40273-016-0382-3
Published Online: 2016-01-28
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hinde, Sebastian http://orcid.org/0000-0002-7117-4142
Wade, Ros
Palmer, Stephen
Woolacott, Nerys
Spackman, Eldon
Funding for this research was provided by:
Health Technology Assessment Programme (GB) (13/168/01)
Text and Data Mining valid from 2016-01-28